Trending Now
Intellia Therapeutics Inc. (NASDAQ: NTLA) Collaborates With Kyverna Therapeutics on Allogeneic...
Intellia Therapeutics Inc. (NASDAQ: NTLA) and Kyverna Therapeutics have announced a licensing and collaboration deal for an allogeneic CD19 chimeric antigen receptor T-cell therapy...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Ardelyx Inc’s (NASDAQ: ARDX) Appeal to the Drug Advisory Committee Gets...
Ardelyx Inc (NASDAQ: ARDX) recently announced that certain health regulatory bodies such as the Centre for Disease Control and the Food and Drugs Authority...
MAKE IT MODERN
LATEST REVIEWS
Crypto Stocks on Sale as Bitcoin Hits Major Support (MARA, EPAZ,...
Every major bull market goes through moments of doubt – perhaps “tests of faith” is a better phrasing. The thesis is still...
MAKE IT MODERN
PERFORMANCE TRAINING
Citius Pharmaceuticals Inc (NASDAQ: CTXR) To Continue Phase 3 Pivotal Superiority Trial after IDMC...
Citius Pharmaceuticals Inc (NASDAQ: CTXR) will continue with its Mino-Lok phase 3 clinical trials following the recommendation by IDMC (Independent Data Monitoring Committee).
IDMC did...
Brickell Biotech Inc. (NASDAQ: BBI) Announces Q3 2021 Financial Results and Sofpironium Bromide gel,...
Brickell Biotech Inc. (NASDAQ: BBI) has announced Q3 2021 financial results and also offered a corporate update about its development programs.
Positive topline results were...
Oncolytics Biotech, Inc. (NASDAQ:ONCY) Says the First Patients has Been Dosed in Phase 2...
Oncolytics Biotech, Inc. (NASDAQ:ONCY) has announced a new study, known as IRENE and under the sponsorship of the Rutgers Cancer Institute of New Jersey,...
Pot Stocks Set for Next Green Wave? (GRWG, NUGS, IIPR, CRON, CGC, HEXO, MSOS)
After a period of dizzying momentum and overvaluation that ended in February, pot stocks have likely overshot in the other direction recently,...
Can-Fite (NYSEAMERICAN:CANF) Submits Investigational New Drug for a Phase II Study of Piclidenoson in...
Can-Fite (NYSEAMERICAN:CANF) has been using its capabilities to develop an innovative pipeline of patented compounds aimed at treating autoimmune-inflammatory and liver diseases. However, with...
MAKE IT MODERN
